{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-113548","form_type":"8-K","ticker":"TRAW","cik":"0001130598","company_name":"Traws Pharma, Inc.","filed_at":"2024-11-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.745496+00:00","generated_at":"2026-05-30T06:49:17.084737+00:00","sec_items":["5.07","8.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Traws Pharma regains bid price compliance but remains at risk of delisting due to equity deficit","bullets":["Regained compliance with Nasdaq minimum bid price requirement as of Oct 29, 2024 after 10 consecutive business days above $1.00.","Company does not believe it satisfies Nasdaq stockholders' equity minimum of $2.5M; reported deficit of ~$(105.5)M as of June 30, 2024.","Will present a plan to regain equity compliance at a Nasdaq hearing scheduled for November 14, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-113548","json":"https://secwatch.observer/filing/0001104659-24-113548.json","markdown":"https://secwatch.observer/filing/0001104659-24-113548.md","text":"https://secwatch.observer/filing/0001104659-24-113548.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1130598/000110465924113548/0001104659-24-113548-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1130598/000110465924113548/tm2427326d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T06:49:17.084737+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}